Por: CNBC Health March 22, 2023
In this articlewatch nowVIDEO1:3201:32Sen. Bernie Sanders grills Moderna CEO over Covid vaccine prices during hearing CEO Stephane Bancel on Wednesday defended the company's plans to hike the price of its Covid shots fivefold, deflecting pressure at a Senate hearing to abandon the increase while taking barbs over his compensation.Moderna plans to raise the list price of its vaccine 400% to $130 when the shots are sold on the private market... + full article
ABC News USA Business March 23, 2023
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Stephane Bancel told the Senate Committee on Health,... + más
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop? | Forbes
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Portland Press Herald USA Health March 23, 2023
Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at drugstores or clinics. Moderna CEO Stephane Bancel testifies during the Senate HELP... + más
Orlando Sentinel USA Nation March 23, 2023
WPLG Local 10 USA Politics March 23, 2023
Associated Press USA Health March 22, 2023
Ars Technica USA Science March 08, 2023
Navigate Filter by topic Settings Front page layout Site theme - Mar 7, 2023 11:22 pm UTC / Moderna pharmaceutical and biotechnology company's CEO Stephane Bancel speaks during a session of the World Economic Forum annual meeting in Davos on January 18, 2023. Share this... + más
CNBC USA Health February 16, 2023
Moderna CEO, Stephane Bancel attends 2019 Forbes Healthcare Summit at the Jazz at Lincoln Center on December 05, 2019 in New York City.Steven Ferdman Getty Images CEO Stéphane Bancel will testify before the Senate health committee in March over the company's price for its... + más
Moderna prepares for transition year as COVID vaccine sales wane, CEO says. | The Boston Globe
Moderna CEO: 400% price hike on COVID vaccine “consistent with the value” | Ars Technica
About iurex | Privacy Policy | Disclaimer |